Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States

IMPORTANCE: Between 2 and 3.5 million people live with chronic hepatitis C virus (HCV) infection in the US, most of whom (approximately 75%) are not aware of their disease. Despite the availability of effective HCV treatment in the early stages of infection, HCV will result in thousands of deaths in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatar, Moosa, Keeshin, Susana W., Mailliard, Mark, Wilson, Fernando A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489814/
https://www.ncbi.nlm.nih.gov/pubmed/32880650
http://dx.doi.org/10.1001/jamanetworkopen.2020.15756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489814/
https://www.ncbi.nlm.nih.gov/pubmed/32880650
http://dx.doi.org/10.1001/jamanetworkopen.2020.15756

Ejemplares similares